Genetic modification of human T cells with CD20: A novel suicide system for the treatment of GVHD.

被引：0
|
作者：
Introna, M
Casati, C
Bambacioni, F
Gaipa, G
Golay, J
Rambaldi, A
Biondi, A
机构：
[1] Ist Ric Farmacol Mario Negri, Mol Immunohematol Lab, Milan, Italy
[2] Univ Milan Bicocca, Ctr Ric Fdn Tettamanti Cura Leucemie, Monza, Italy
[3] Osped Riuniti Bergamo, Div Hematol, I-24100 Bergamo, Italy
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
912
引用
收藏
页码：214A / 214A
页数：1
相关论文
共 50 条
  • [1] The CD20/αCD20 'suicide' system:: novel vectors with improved safety and expression profiles and efficient elimination of CD20-transgenic T cells
    van Meerten, T
    Claessen, MJ
    Hagenbeek, A
    Ebeling, SB
    [J]. GENE THERAPY, 2006, 13 (09) : 789 - 797
  • [2] The CD20/αCD20 ‘suicide’ system: novel vectors with improved safety and expression profiles and efficient elimination of CD20-transgenic T cells
    T van Meerten
    M-J Claessen
    A Hagenbeek
    S B Ebeling
    [J]. Gene Therapy, 2006, 13 : 789 - 797
  • [3] Genetic modification of human T cells with CD20: A strategy to purify and lyse transduced cells with anti-CD20 antibodies
    Introna, M
    Barbui, AM
    Bambacioni, F
    Casati, C
    Gaipa, G
    Borleri, G
    Bernasconi, S
    Barbui, T
    Golay, J
    Biondi, A
    Rambaldi, A
    [J]. HUMAN GENE THERAPY, 2000, 11 (04) : 611 - 620
  • [4] Genetic modification of human T cells with CD20: A strategy to purify and lyse transduced cells with anti-CD20 antibodies.
    Introna, M
    Barbui, AM
    Bambacioni, F
    Casati, C
    Gaipa, G
    Borleri, GM
    Bernasconi, S
    Barbui, T
    Golay, J
    Biondi, A
    Rambaldi, A
    [J]. BLOOD, 1999, 94 (10) : 411B - 411B
  • [5] Preclinical development of the CD20 suicide gene system in T and NK cells.
    Introna, M
    Manganini, M
    Bonamino, M
    Broady, R
    Biondi, A
    Rambaldi, A
    Serafini, M
    [J]. BLOOD, 2002, 100 (11) : 650A - 650A
  • [6] High, stable and homogenous CD20 expression for efficient rituximab-induced elimination of CD20+ alloreactive donor T cells in the novel CD20/Rituximab 'suicide' system
    van Meerten, T
    Claessen, MJ
    Hagenbeek, A
    Ebeling, S
    [J]. BLOOD, 2004, 104 (11) : 485A - 485A
  • [7] In vivo model of novel CD20 suicide gene system.
    Introna, M
    Di Gaetano, N
    Cittera, E
    Golay, J
    [J]. BLOOD, 2001, 98 (11) : 421A - 421A
  • [8] Retroviral transfer of human CD20 as a suicide gene for adoptive T-cell therapy
    Griffioen, Marieke
    van Egmond, Esther H. M.
    Kester, Michel G. D.
    Willemze, Roel
    Falkenburg, J. H. Frederik
    Heemskerk, Mirjam H. M.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 (09): : 1316 - 1320
  • [9] Ex vivo Fas ligand treatment selectively eliminates T cells that mediate GVHD.
    Kashtan, Osnat
    Levitsky, Hyam I.
    Civin, Curt I.
    [J]. BLOOD, 2006, 108 (11) : 904A - 904A
  • [10] CD4+ CD25bright Regulatory T Cells Prevent Acute Xenogeneic GVHD.
    Huang, Y.
    Merchak, A.
    Xu, H.
    Chhabra, A.
    Khalil, A.
    Wen, Y.
    Binion, M.
    Badder, M.
    Kahn, L.
    Ildstad, S.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 619 - 620
12345